[go: up one dir, main page]

CN104865323B - The assay method of hydrogen sulfide in a kind of blood and urine - Google Patents

The assay method of hydrogen sulfide in a kind of blood and urine Download PDF

Info

Publication number
CN104865323B
CN104865323B CN201510208671.1A CN201510208671A CN104865323B CN 104865323 B CN104865323 B CN 104865323B CN 201510208671 A CN201510208671 A CN 201510208671A CN 104865323 B CN104865323 B CN 104865323B
Authority
CN
China
Prior art keywords
blood
urine
hydrogen sulfide
magnetic
iron salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510208671.1A
Other languages
Chinese (zh)
Other versions
CN104865323A (en
Inventor
杨亚玲
赵娇
廖文龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming University of Science and Technology
Original Assignee
Kunming University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming University of Science and Technology filed Critical Kunming University of Science and Technology
Priority to CN201510208671.1A priority Critical patent/CN104865323B/en
Publication of CN104865323A publication Critical patent/CN104865323A/en
Application granted granted Critical
Publication of CN104865323B publication Critical patent/CN104865323B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a kind of method that dispersed solid phase micro-extraction combines the hydrogen sulfide in high-performance liquid chromatogram determination blood and urine, utilize free H in serum and urine2S、HS、S2‑With P-aminodimethylaniline hydrochlorate and ferric chloride derivative formation methylene blue in acid condition, by adding modified magnetic nano material, methylene blue is adsorbed, under the effect of externally-applied magnetic field, magnetic material is separated with matrix, remove the interference that in blood, urine, macromolecular complex confrontation measures.With a small amount of eluant, magnetic material being carried out eluting, eluent high performance liquid chromatography quantitative determines, and detection limit is up to 0.005 μ g/mL;Method has accuracy, the feature such as highly sensitive, simple and quick.

Description

一种血液及尿液中硫化氢的测定方法A kind of determination method of hydrogen sulfide in blood and urine

技术领域technical field

本发明属于体内药物检测技术领域,具体涉及一种血液及尿液中硫化氢的检测方法,特别是一种分散固相微萃取结合高效液相色谱测定血液及尿液中的硫化氢的方法。The invention belongs to the technical field of drug detection in vivo, and in particular relates to a method for detecting hydrogen sulfide in blood and urine, in particular to a method for detecting hydrogen sulfide in blood and urine combined with dispersed solid-phase microextraction and high-performance liquid chromatography.

背景技术Background technique

在心血管系统中,硫化氢(H2S)能开放ATP敏感的钾离子通道,使血管平滑肌舒张,降低血压;体内H2S生成减少与自发性高血压的形成有密切关系;外源性给予H2S能有效保护心肌的缺血性损伤。由于能在体内产生,并具有多种生理功能,H2S成为继NO和CO后的第三个气体信号分子。越来越多的证据表明内源性H2S与多种疾病有着密切的关系,在临床多种疾病中,内源性H2S的生成和代谢发生了改变,并进一步影响了疾病的发展过程,以H2S为靶点的治疗具有潜在的临床应用前景;一种可靠、准确的血液、尿液中内源性H2S的测定方法对监测体内H2S含量及相关疾病的预测及诊断有重要意义。In the cardiovascular system, hydrogen sulfide (H 2 S) can open ATP-sensitive potassium ion channels, relax vascular smooth muscle, and lower blood pressure; the reduction of H 2 S production in the body is closely related to the formation of spontaneous hypertension; exogenous administration H 2 S can effectively protect myocardial ischemic injury. Since it can be produced in vivo and has various physiological functions, H 2 S becomes the third gas signal molecule after NO and CO. More and more evidence shows that endogenous H 2 S is closely related to various diseases. In many clinical diseases, the production and metabolism of endogenous H 2 S are changed, and further affect the development of the disease The treatment with H 2 S as the target has potential clinical application prospects; a reliable and accurate method for the determination of endogenous H 2 S in blood and urine is useful for monitoring H 2 S content in the body and predicting related diseases and diagnosis are important.

H2S检测方法主要包括亚甲基兰分光光度法、硫离子选择电极法、荧光衍生法、气相色谱法、荧光探针及免疫分析法等。目前现有H2S检测技术主要集中在大气、水等环境样品中,其检测灵敏度在1mg/kg,而体内内源性硫化氢(H2S)含量在μmol级。研究小组之前已利用分散液液微萃取结合光度法、共沉淀结合高效液相色谱法对血液及尿液H2S检测进行了研究,取得了不错的效果,申请了发明专利(201410382081)及(201410062197)。进一步研究发现,血液及尿液由于基体复杂,存在颜色、蛋白、脂肪的影响,共沉淀及液液微萃取存在基体分离不完全的问题。H 2 S detection methods mainly include methylene blue spectrophotometry, sulfide ion selective electrode method, fluorescence derivatization method, gas chromatography, fluorescent probe and immunoassay. At present, the existing H 2 S detection technology mainly focuses on environmental samples such as air and water, and its detection sensitivity is 1 mg/kg, while the content of endogenous hydrogen sulfide (H 2 S) in the body is at the μmol level. The research team has previously used dispersion liquid-liquid microextraction combined with photometry, co-precipitation combined with high performance liquid chromatography to study the detection of H 2 S in blood and urine, and achieved good results, and applied for invention patents (201410382081) and ( 201410062197). Further research found that due to the complex matrix of blood and urine, there are effects of color, protein, and fat, and there is a problem of incomplete matrix separation in coprecipitation and liquid-liquid microextraction.

发明内容Contents of the invention

本发明的目的在于针对现有技术的不足,提供一种稳定性好、干扰小、准确、灵敏、快速测定血液及尿液中硫化氢含量的方法。The object of the present invention is to aim at the deficiencies of the prior art, to provide a method with good stability, little interference, accuracy, sensitivity and rapid determination of hydrogen sulfide content in blood and urine.

本发明利用硅酸纳改性的磁性纳米材料(Fe3O4@SiO2)吸附硫化氢衍生物亚甲基蓝,对目标物进行快速富集,在磁场作用下能够快速将基体与磁性材料分离。由于磁性吸附剂与目标物之间的磁性吸附具有特异性,因而,避免了溶液中的悬浊颗粒对于整个吸附过程的影响,降低了基质干扰同时提高了检测灵敏度。本发明利用磁性材料结合高效液相色谱(HPLC)法,一是利用磁性材料能高效分离血液、尿液中的干扰物质;二是对硫离子衍生物亚甲基兰能快速吸附;三是洗脱剂用量小,洗脱快速,检测限可0.005μg/mL;四是纳米磁性材料可以重复用到3次以上。The invention utilizes sodium silicate-modified magnetic nanometer material (Fe 3 O 4 @SiO 2 ) to adsorb methylene blue, a hydrogen sulfide derivative, to rapidly enrich the target substance, and can rapidly separate the matrix from the magnetic material under the action of a magnetic field. Due to the specificity of the magnetic adsorption between the magnetic adsorbent and the target, the influence of the suspended particles in the solution on the entire adsorption process is avoided, the matrix interference is reduced and the detection sensitivity is improved at the same time. The present invention utilizes magnetic material in conjunction with high-performance liquid chromatography (HPLC) method, the one, utilize magnetic material to efficiently separate the interfering substance in blood, urine; The amount of detaching agent is small, the elution is fast, and the detection limit can be 0.005 μg/mL; Fourth, the nano-magnetic material can be reused more than 3 times.

除非另有说明,本发明所采用的百分数均为重量百分数。Unless otherwise stated, the percentages used in the present invention are all percentages by weight.

本发明的目的通过以下技术方案予以实现:The purpose of the present invention is achieved through the following technical solutions:

以制备的硅酸纳改性的磁性纳米材料(Fe3O4@SiO2)为固相萃取剂,按每5mL尿液或处理过的血液中加入质量百分比浓度为0.2%对氨基二甲基苯胺盐酸盐溶液100~200μL,再加入质量百分比浓度为20%三氯化铁溶液50~100μL,混合均匀,静置5~10min;加入5mol/LNaOH溶液将样品pH调至中性,3000r/min离心2~5min,吸取上清液;向上清液中加入1~3mg固相萃取剂,涡旋1~2min使固相萃取剂均匀分散在水中,然后静置5~10min后,用外磁场收集带有目标物的固相萃取剂,去掉上清液,用洗脱剂洗脱固相萃取剂,收集洗脱液,采用设置的高效液相色谱条件进行含量测定。Using the prepared sodium silicate-modified magnetic nanomaterial (Fe 3 O 4 @SiO 2 ) as the solid-phase extraction agent, add 0.2% p-aminodimethyl Add 100-200 μL of aniline hydrochloride solution, then add 50-100 μL of 20% ferric chloride solution by mass percentage, mix well, and let stand for 5-10 minutes; add 5mol/L NaOH solution to adjust the pH of the sample to neutral, 3000r/ Min centrifuge for 2-5min, absorb the supernatant; add 1-3mg solid phase extractant to the supernatant, vortex for 1-2min to disperse the solid-phase extractant evenly in the water, then let it stand for 5-10min, then use an external magnetic field Collect the solid phase extraction agent with the target substance, remove the supernatant, elute the solid phase extraction agent with the eluent, collect the eluent, and use the set high performance liquid chromatography conditions for content determination.

所述硅酸钠改性的磁性纳米材料(Fe3O4@SiO2)的制备包括以下步骤:The preparation of the sodium silicate modified magnetic nanomaterial (Fe 3 O 4 @SiO 2 ) includes the following steps:

①Fe3O4磁性纳米材料的制备:按照三价铁盐与二价铁盐摩尔比为2.0~1.6:1的比例将三价铁盐溶液与二价铁盐溶液溶解于5~10倍的三价铁盐与二价铁盐溶液体积的去离子水中,在氮气保护下,滴加氨水使溶液体系pH为9~12,在60~80℃、搅拌速度400~800rpm下,水浴加热,恒温搅拌反应1~3h后,用去离子水洗涤至中性,40~80℃真空干燥6~12h,制得四氧化三铁磁性纳米材料;①Preparation of Fe 3 O 4 magnetic nanomaterials: Dissolve the ferric salt solution and the ferrous salt solution in 5 to 10 times the In deionized water with the volume of valent iron salt and divalent iron salt solution, under the protection of nitrogen, add ammonia water dropwise to make the pH of the solution system 9-12, heat in a water bath at 60-80°C, stirring speed 400-800rpm, and stir at a constant temperature After reacting for 1-3 hours, wash with deionized water until neutral, and vacuum-dry at 40-80°C for 6-12 hours to prepare ferroferric oxide magnetic nanomaterials;

②Fe3O4@SiO2磁性纳米材料的制备:按1.0g Fe3O4磁性纳米材料添加100 mL去离子水的比例将步骤①制备好的Fe3O4磁性纳米材料分散在去离子水中,并在氮气保护下,滴加1.0 mol/L硅酸钠10 mL至Fe3O4纳米分散液中,使体系pH为6~7,在70~85℃、搅拌速度400~800 rpm下,恒温搅拌反应2~4h后,用去离子水洗涤4次,40~80℃真空干燥6~12h,制得Fe3O4@SiO2磁性纳米材料。②Preparation of Fe 3 O 4 @SiO 2 magnetic nanomaterials: Disperse the Fe 3 O 4 magnetic nanomaterials prepared in step ① in deionized water at the ratio of 1.0 g of Fe 3 O 4 magnetic nanomaterials to 100 mL of deionized water, And under the protection of nitrogen, drop 1.0 mol/L sodium silicate 10 mL into the Fe 3 O 4 nano-dispersion to make the pH of the system 6-7. After stirring and reacting for 2-4 hours, wash with deionized water for 4 times, and vacuum-dry at 40-80° C. for 6-12 hours to prepare Fe 3 O 4 @SiO 2 magnetic nanomaterials.

所述的三价铁盐为FeCl3·7H2O或Fe2(SO4)3·9H2O,二价铁盐为FeCl2·4H2O或FeSO4·7H2O。The ferric salt is FeCl 3 .7H 2 O or Fe 2 (SO 4 ) 3 .9H 2 O, and the ferric salt is FeCl 2 .4H 2 O or FeSO 4 .7H 2 O.

所述处理过的血液是指取5mL新鲜血液,2000r/min离心10min,将血清转移至离心管中用蒸馏水定容至5 mL。The treated blood refers to taking 5 mL of fresh blood, centrifuging at 2000 r/min for 10 min, transferring the serum to a centrifuge tube and distilling it to 5 mL with distilled water.

所述0.2%对氨基二甲基苯胺盐酸盐溶液是0.1g对氨基二甲基苯胺盐酸盐溶于50mL 3mol/L盐酸制得。The 0.2% p-aminodimethylaniline hydrochloride solution is prepared by dissolving 0.1 g of p-aminodimethylaniline hydrochloride in 50 mL of 3mol/L hydrochloric acid.

所述的三氯化铁溶液为按10g三氯化铁溶于50mL蒸馏水中的比例配制的。The ferric chloride solution is prepared by dissolving 10g of ferric chloride in 50mL of distilled water.

所述的洗脱剂甲醇、乙腈、丙酮中的一种,用量为300-600μL。One of the eluents methanol, acetonitrile and acetone is used in an amount of 300-600 μL.

所述的高效液相色谱测定的色谱条件为:固定相为C18的分析色谱柱,洗脱液为甲醇:水(体积比50:50),洗脱方式为等度洗脱;流速为1.0mL/min;进样量为10μL,柱温25℃;紫外-可见光二极管阵列检测器的检测波长为665nm。The chromatographic conditions for the HPLC determination are as follows: the stationary phase is an analytical chromatographic column of C18, the eluent is methanol:water (volume ratio 50:50), and the elution method is isocratic elution; the flow rate is 1.0mL /min; the injection volume was 10 μL, the column temperature was 25 °C; the detection wavelength of the ultraviolet-visible light diode array detector was 665 nm.

相对于现有技术,本发明具有以下显著优点:Compared with the prior art, the present invention has the following significant advantages:

1、S2-与对氨基二甲基苯胺盐酸盐和三氯化铁在酸性条件下衍生形成亚甲基蓝,通过加入改性磁性纳米材料对亚甲基蓝进行吸附,在外加磁场的作用下将磁性材料与基体分离,用少量洗脱剂对磁性材料进行洗脱;既使S2-衍生物与复杂的基体得到了分离,又对硫离子进行了浓缩富集,检测限可达0.005μg/mL;1. S 2- is derivatized with p-aminodimethylaniline hydrochloride and ferric chloride under acidic conditions to form methylene blue, and the methylene blue is adsorbed by adding modified magnetic nanomaterials, and the magnetic material and Matrix separation, using a small amount of eluent to elute the magnetic material; not only the S 2- derivatives are separated from the complex matrix, but also the sulfur ions are concentrated and enriched, and the detection limit can reach 0.005μg/mL;

2、分散固相微萃取过程具有简单、快速、稳定性好,易操作的特点,流程见图1,体内硫化氢的检测存在基体干扰大,含量低的现状,提供快速、简便、直观的定性和定量测定。2. The dispersive solid-phase microextraction process has the characteristics of simplicity, speed, good stability and easy operation. The flow chart is shown in Figure 1. The detection of hydrogen sulfide in the body has the status of large matrix interference and low content, providing fast, simple and intuitive qualitative and quantitative determination.

附图说明Description of drawings

图1为分散固相微萃取流程示意图;Fig. 1 is the schematic diagram of dispersion solid-phase microextraction process;

图2为血液中H2S经Fe3O4@SiO2磁性纳米材料富集与未富集对比色谱图。Fig. 2 is a chromatogram comparing H 2 S enrichment and non-enrichment by Fe 3 O 4 @SiO 2 magnetic nanomaterials in blood.

具体实施方式detailed description

下面结合实施例对本发明作进一步地说明,但本发明的保护范围并不限于此。The present invention will be further described below in conjunction with the examples, but the protection scope of the present invention is not limited thereto.

实施例1:利用本方法检测人体尿液中硫化氢的含量Embodiment 1: Utilize this method to detect the content of hydrogen sulfide in human urine

1、Fe3O4磁性纳米材料的制备:将2mol/L FeCl3·7H2O 12mL与1mol/L FeCl2·4H2O12mL混合于120mL去离子水中,在氮气保护下,滴加50mL氨水使体系pH为9,在60℃下水浴加热,搅拌速度为400 rpm下,恒温搅拌反应3h后,用去离子水洗涤至中性,70℃真空干燥8h,制得Fe3O4性纳米材料;1. Preparation of Fe 3 O 4 magnetic nanomaterials: 2mol/L FeCl 3 7H 2 O 12mL and 1mol/L FeCl 2 4H 2 O 12mL were mixed in 120mL deionized water, and under nitrogen protection, 50mL ammonia water was added dropwise to make The pH of the system is 9, heated in a water bath at 60°C, and the stirring speed is 400 rpm. After stirring and reacting at a constant temperature for 3 hours, it is washed with deionized water until neutral, and vacuum-dried at 70°C for 8 hours to obtain Fe 3 O 4 nanomaterials;

2、Fe3O4@SiO2磁性纳米材料的制备:将步骤1制备好的Fe3O4磁性纳米材料1.0 g分散在100 mL去离子水中,在氮气保护下,滴加1.0 mol/L硅酸钠10 mL至Fe3O4纳米分散液中,使体系pH为6,在70℃、搅拌速度800rpm下,恒温搅拌反应2h后,用去离子水洗涤4次,40℃真空干燥12h,制得Fe3O4@SiO2磁性纳米材料;2. Preparation of Fe 3 O 4 @SiO 2 magnetic nanomaterials: Disperse 1.0 g of Fe 3 O 4 magnetic nanomaterials prepared in step 1 in 100 mL deionized water, and add 1.0 mol/L silicon Add 10 mL of Na2SO4 to the Fe 3 O 4 nano-dispersion liquid to make the pH of the system 6. After reacting for 2 hours with constant temperature stirring at 70°C and a stirring speed of 800 rpm, wash with deionized water 4 times, and vacuum-dry at 40°C for 12 hours to prepare Obtain Fe 3 O 4 @SiO 2 magnetic nanomaterials;

3、尿液的检测:取5mL尿液至10mL离心管中,加入0.2%对氨基二甲基苯胺盐酸盐溶液(0.1g对氨基二甲基苯胺盐酸盐溶于50mL 3mol/L盐酸制得)200μL,再加入20%三氯化铁溶液50μL,混合均匀,静置5min;然后加入5mol/L NaOH溶液将样品pH调至中性,3000r/min离心2min,吸取上清液;向上清液中加入Fe3O4@SiO2磁性材料2mg,涡旋混合1min,静置5min;用磁铁贴近试管壁,将磁性材料与样品溶液分离,倾倒出上清液;用400μL乙腈对磁性材料进行洗脱,洗脱液用0.45μm滤膜进行过滤;进高效液相,测定的色谱条件为:固定相为C18的分析色谱柱,洗脱液为体积比50︰50的甲醇和水的混合液,洗脱方式为等度洗脱;流速为1.0mL/min;进样量为10μL,柱温25℃;紫外-可见光二极管阵列检测器的检测波长为665nm,得到尿液中硫化氢的含量为0.065μg/mL(见图2)。3. Urine detection: Take 5mL urine into a 10mL centrifuge tube, add 0.2% p-aminodimethylaniline hydrochloride solution (0.1g p-aminodimethylaniline hydrochloride dissolved in 50mL 3mol/L hydrochloric acid (obtained) 200 μL, then add 50 μL of 20% ferric chloride solution, mix well, and let it stand for 5 minutes; then add 5mol/L NaOH solution to adjust the pH of the sample to neutral, centrifuge at 3000r/min for 2min, absorb the supernatant; Add 2 mg of Fe 3 O 4 @SiO 2 magnetic material to the solution, vortex and mix for 1 min, and let stand for 5 min; use a magnet close to the wall of the test tube to separate the magnetic material from the sample solution, and pour out the supernatant; For elution, the eluent is filtered with a 0.45 μm filter membrane; into high performance liquid phase, the chromatographic conditions for determination are: the stationary phase is an analytical chromatographic column of C18, and the eluent is a mixture of methanol and water with a volume ratio of 50:50 The elution method is isocratic elution; the flow rate is 1.0mL/min; the injection volume is 10μL, the column temperature is 25°C; the detection wavelength of the ultraviolet-visible light diode array detector is 665nm, and the content of hydrogen sulfide in urine is obtained 0.065μg/mL (see Figure 2).

实施例2:利用本方法检测人体尿液中硫化氢的含量Embodiment 2: Utilize this method to detect the content of hydrogen sulfide in human urine

1、Fe3O4磁性纳米材料的制备:将2mol/L FeCl3·7H2O 12mL与1mol/L FeSO4·7H2O15mL混合于150mL去离子水中,在氮气保护下,滴加50mL氨水使体系pH为10,在70℃下水浴加热,搅拌速度为600 rpm下,恒温搅拌反应1.5h后,用去离子水洗涤至中性,40℃真空干燥12h,制得Fe3O4性纳米材料;1. Preparation of Fe 3 O 4 magnetic nanomaterials: Mix 2mol/L FeCl 3 7H 2 O 12mL and 1mol/L FeSO 4 7H 2 O 15mL in 150mL deionized water, and add 50mL ammonia water dropwise under nitrogen protection to make The pH of the system was 10, heated in a water bath at 70°C, and the stirring speed was 600 rpm. After stirring at a constant temperature for 1.5 hours, it was washed with deionized water until neutral, and vacuum-dried at 40°C for 12 hours to obtain Fe 3 O 4 nanomaterials. ;

2、Fe3O4@SiO2磁性纳米材料的制备:将步骤1制备好的Fe3O4磁性纳米材料1.0g分散在100 mL去离子水中,在氮气保护下,滴加1.0mol/L硅酸钠10 mL至Fe3O4纳米分散液中,使体系pH为6.5,在75℃、搅拌速度600rpm下,恒温搅拌反应2.5h后,用去离子水洗涤4次,50℃真空干燥10h,制得Fe3O4@SiO2磁性纳米材料;2. Preparation of Fe 3 O 4 @SiO 2 magnetic nanomaterials: Disperse 1.0 g of Fe 3 O 4 magnetic nanomaterials prepared in step 1 in 100 mL deionized water, and add 1.0 mol/L silicon Add 10 mL of sodium bicarbonate into the Fe 3 O 4 nano-dispersion liquid to make the pH of the system 6.5. After stirring and reacting at a constant temperature for 2.5 hours at 75°C and a stirring speed of 600 rpm, wash with deionized water for 4 times, and vacuum-dry at 50°C for 10 hours. Prepare Fe 3 O 4 @SiO 2 magnetic nanomaterials;

3、尿液的检测:取5mL尿液至10mL离心管中,加入0.2%对氨基二甲基苯胺盐酸盐溶液(0.1g对氨基二甲基苯胺盐酸盐溶于50mL 3mol/L盐酸制得)150μL,再加入质量体积比浓度20%三氯化铁水溶液80μL,混合均匀,静置7min,加入5mol/L NaOH溶液将样品pH调至中性,3000r/min离心3min,吸取上清液,向上清液中加入Fe3O4@SiO2磁性材料1mg,涡旋混合1.5min,静置8min;用磁铁贴近试管壁,将磁性材料与样品溶液分离,倾倒出上清液。用500μL甲醇对磁性材料进行洗脱,洗脱液用0.45μm滤膜进行过滤,进高效液相在665nm波长下进行测定(条件同实施例1),得到尿液中硫化氢的含量为0.035μg/mL。3. Urine detection: Take 5mL urine into a 10mL centrifuge tube, add 0.2% p-aminodimethylaniline hydrochloride solution (0.1g p-aminodimethylaniline hydrochloride dissolved in 50mL 3mol/L hydrochloric acid (obtained) 150 μL, then add 80 μL of 20% ferric chloride aqueous solution by mass volume ratio, mix well, let stand for 7 minutes, add 5mol/L NaOH solution to adjust the pH of the sample to neutral, centrifuge at 3000r/min for 3min, and absorb the supernatant , add 1 mg of Fe 3 O 4 @SiO 2 magnetic material to the supernatant, vortex and mix for 1.5 min, and let stand for 8 min; use a magnet to close the test tube wall, separate the magnetic material from the sample solution, and pour out the supernatant. The magnetic material was eluted with 500 μL of methanol, and the eluate was filtered with a 0.45 μm filter membrane, and then entered into high performance liquid phase for measurement at a wavelength of 665 nm (the conditions were the same as in Example 1), and the content of hydrogen sulfide in the urine was 0.035 μg /mL.

实施例 3:利用本发明检测人体血液中硫化氢的含量Embodiment 3: Using the present invention to detect the content of hydrogen sulfide in human blood

1、Fe3O4磁性纳米材料的制备:将2mol/L Fe2(SO4)3·9H2O 10mL与1mol/L FeSO4·7H2O 12mL混合于150mL去离子水中,在氮气保护下,滴加50mL氨水使体系pH为11,在80℃下水浴加热,搅拌速度为500rpm下,恒温搅拌反应2h后,用去离子水洗涤至中性,50℃真空干燥10h,制得四氧化三铁磁性纳米材料;1. Preparation of Fe 3 O 4 magnetic nanomaterials: 2mol/L Fe 2 (SO 4 ) 3 9H 2 O 10mL and 1mol/L FeSO 4 7H 2 O 12mL were mixed in 150mL deionized water, under nitrogen protection , add 50mL of ammonia water dropwise to make the pH of the system 11, heat in a water bath at 80°C, stir at 500rpm, stir and react at a constant temperature for 2h, wash with deionized water until neutral, and dry in vacuum at 50°C for 10h to obtain trioxide ferromagnetic nanomaterials;

2、Fe3O4@SiO2磁性纳米材料的制备:将步骤1制备好的Fe3O4磁性纳米材料1.0 g分散在100 mL去离子水中,在氮气保护下,滴加1.0 mol/L硅酸钠10 mL至Fe3O4纳米分散液中,使体系pH为7,在85℃、搅拌速度400rpm下,恒温搅拌反应3h后,用去离子水洗涤4次,60℃真空干燥8h,制得Fe3O4@SiO2磁性纳米材料;2. Preparation of Fe 3 O 4 @SiO 2 magnetic nanomaterials: Disperse 1.0 g of Fe 3 O 4 magnetic nanomaterials prepared in step 1 in 100 mL deionized water, and add 1.0 mol/L silicon Add 10 mL of sodium bicarbonate into the Fe 3 O 4 nano-dispersion liquid, make the pH of the system 7, stir at 85°C and 400 rpm at a constant temperature for 3 hours, wash with deionized water for 4 times, and dry in vacuum at 60°C for 8 hours to prepare Obtain Fe 3 O 4 @SiO 2 magnetic nanomaterials;

3、血液的检测:取5mL新鲜血液至10mL离心管中,2000r/min离心10min,将血清转移至新离心管中用蒸馏水定容至5 mL,加入0.2%对氨基二甲基苯胺盐酸盐溶液(0.1g对氨基二甲基苯胺盐酸盐溶于50mL 3mol/L盐酸制得)100μL,再加入质量体积比浓度20%的三氯化铁水溶液100μL,混合均匀,静置10min,加入5mol/L NaOH溶液将样品pH调至中性,3000r/min离心5min,吸取上清液,向上清液中加入Fe3O4@SiO2 磁性材料3mg,涡旋混合2min,静置10min,用磁铁贴近试管壁,将磁性材料与样品溶液分离,倾倒出上清液,用600μL丙酮对磁性材料进行洗脱,洗脱液用0.45μm滤膜过滤,进高效液相在665nm波长下进行测定(条件同实施例1),得到出血液中硫化氢的含量为0.0082μg/mL。3. Blood test: take 5mL of fresh blood into a 10mL centrifuge tube, centrifuge at 2000r/min for 10min, transfer the serum to a new centrifuge tube, dilute to 5 mL with distilled water, add 0.2% p-aminodimethylaniline hydrochloride Solution (prepared by dissolving 0.1g p-aminodimethylaniline hydrochloride in 50mL 3mol/L hydrochloric acid) 100μL, then add 100μL of ferric chloride aqueous solution with a mass volume ratio concentration of 20%, mix well, let stand for 10min, add 5mol /L NaOH solution to adjust the pH of the sample to neutral, centrifuge at 3000r/min for 5min, absorb the supernatant, add 3mg of Fe 3 O 4 @SiO 2 magnetic material to the supernatant, vortex and mix for 2min, let it stand for 10min, and use a magnet Close to the test tube wall, separate the magnetic material from the sample solution, pour out the supernatant, elute the magnetic material with 600 μL acetone, filter the eluate with a 0.45 μm filter membrane, enter the high performance liquid phase and measure it at a wavelength of 665nm ( The conditions are the same as in Example 1), and the content of hydrogen sulfide in the blood is 0.0082 μg/mL.

实施例 4:利用本发明检测人体血液中硫化氢的含量Example 4: Using the present invention to detect the content of hydrogen sulfide in human blood

1、Fe3O4磁性纳米材料的制备:将2mol/L FeCl3·7H2O 10mL与1mol/L FeSO4·7H2O 11mL混合于160mL去离子水中,在氮气保护下,滴加50mL氨水使体系pH为12,在60℃下水浴加热,搅拌速度为800 rpm下,恒温搅拌反应1h后,用去离子水洗涤至中性,60℃真空干燥8h,制得四氧化三铁磁性纳米材料;1. Preparation of Fe 3 O 4 magnetic nanomaterials: Mix 2mol/L FeCl 3 7H 2 O 10mL and 1mol/L FeSO 4 7H 2 O 11mL in 160mL deionized water, and add 50mL ammonia water dropwise under nitrogen protection Make the pH of the system 12, heat in a water bath at 60°C, stir at 800 rpm, stir and react at a constant temperature for 1 hour, wash with deionized water until neutral, and dry in vacuum at 60°C for 8 hours to prepare ferroferric oxide magnetic nanomaterials ;

2、Fe3O4@SiO2磁性纳米材料的制备:将步骤1制备好的Fe3O4磁性纳米材料1.0g分散在100 mL去离子水中,在氮气保护下,滴加1.0 mol/L硅酸钠10mL至Fe3O4纳米分散液中,使体系pH为7,在80℃、搅拌速度500rpm下,恒温搅拌反应3h后,用去离子水洗涤4次,80℃真空干燥6h,制得Fe3O4@SiO2磁性纳米材料;2. Preparation of Fe 3 O 4 @SiO 2 magnetic nanomaterials: Disperse 1.0 g of Fe 3 O 4 magnetic nanomaterials prepared in step 1 in 100 mL deionized water, and add 1.0 mol/L silicon Add 10mL of Na2SO4 to the nano-dispersion of Fe 3 O 4 to make the pH of the system 7. After reacting at 80°C with a stirring speed of 500rpm at a constant temperature for 3h, wash 4 times with deionized water and dry in vacuum at 80°C for 6h to obtain Fe 3 O 4 @SiO 2 magnetic nanomaterials;

3、血液的检测:取5mL新鲜血液至10mL离心管中,2000r/min离心10min,将血清转移至新离心管中用蒸馏水定容至5 mL,加入0.2%对氨基二甲基苯胺盐酸盐溶液(0.1g对氨基二甲基苯胺盐酸盐溶于50mL 3mol/L盐酸制得)100μL,再加入质量体积比浓度为20%三氯化铁水溶液50μL,混合均匀,静置8min,加入5mol/L NaOH溶液将样品pH调至中性,3000r/min离心4min,吸取上清液,向上清液中加入Fe3O4@SiO2磁性材料1mg,涡旋混合2 min,静置8min,用一块磁铁贴近试管壁,将磁性材料与样品溶液分离,倾倒出上清液。用300μL乙腈对磁性材料进行洗脱,洗脱液用0.45μm滤膜过滤。进高效液相在665nm波长下进行测定(条件同实施例1),得到血液中硫化氢的含量为0.049μg/mL。3. Blood test: take 5mL of fresh blood into a 10mL centrifuge tube, centrifuge at 2000r/min for 10min, transfer the serum to a new centrifuge tube, dilute to 5 mL with distilled water, add 0.2% p-aminodimethylaniline hydrochloride Solution (0.1g of p-aminodimethylaniline hydrochloride dissolved in 50mL 3mol/L hydrochloric acid) 100μL, then add 50μL of ferric chloride aqueous solution with a mass volume ratio concentration of 20%, mix well, let stand for 8min, add 5mol /L NaOH solution to adjust the pH of the sample to neutral, centrifuge at 3000r/min for 4min, absorb the supernatant, add 1mg of Fe 3 O 4 @SiO 2 magnetic material to the supernatant, vortex and mix for 2 minutes, let stand for 8min, and use A magnet is attached to the wall of the test tube, the magnetic material is separated from the sample solution, and the supernatant is poured out. The magnetic material was eluted with 300 μL of acetonitrile, and the eluate was filtered with a 0.45 μm filter membrane. Enter high performance liquid phase and measure at a wavelength of 665nm (the conditions are the same as in Example 1), and the content of hydrogen sulfide in the blood is 0.049 μg/mL.

Claims (4)

1. the assay method of hydrogen sulfide in a blood and urine, it is characterised in that: receive with the magnetic that the sodium silicate of preparation is modified Rice material is solid extracting agent, adds 0.2% P-aminodimethylaniline hydrochlorate by every 5mL urine or the blood that processed Solution 100~200 μ L, adds the ferric chloride aqueous solutions 50~100 μ L of mass volume ratio concentration 20%, mix homogeneously, stands 5~10min;Being subsequently adding 5mol/L NaOH solution regulation pH the most neutral, 3000r/min is centrifuged 2~5min, Aspirate supernatant; Adding 1~3mg solid extracting agent in supernatant, vortex 1~2min makes solid extracting agent be dispersed in water, then stands After 5~10min, collect the solid extracting agent with object by external magnetic field, remove supernatant, use eluent Solid-Phase Extraction Agent, collects eluent, uses high performance liquid chromatograph to carry out assay;
The preparation of the magnetic Nano material that described sodium silicate is modified comprises the following steps:
①Fe3O4The preparation of magnetic Nano material: will according to the ratio that trivalent iron salt and divalent iron salt mol ratio are 2.0~1.6:1 Ferric salt solution and divalent iron salt solution are dissolved in the trivalent iron salt of 5~10 times and the deionized water of divalent iron salt liquor capacity In, under nitrogen protection, dropping ammonia makes solution system pH be 9~12, at 60~80 DEG C, mixing speed 400~800 rpm Under, heating in water bath, after constant temperature stirring reaction 1~3h, it is washed with deionized to neutrality, 40~80 DEG C of vacuum drying 6~12h, Prepare ferroferric oxide magnetic nano-material;
②Fe3O4@SiO2The preparation of magnetic Nano material: by 1.0g Fe3O4Magnetic Nano material adds 100 mL deionized waters The Fe that 1. step is prepared by ratio3O4Magnetic Nano material disperses in deionized water, and under nitrogen protection, drips 1.0 Mol/L sodium silicate 10 mL to Fe3O4In nano dispersion fluid, the system pH of making is 6~7,70~85 DEG C, mixing speed 400~ Under 800rpm, after constant temperature stirring reaction 2~4h, it is washed with deionized 4 times, 40~80 DEG C of vacuum drying 6~12h, prepares Fe3O4@SiO2Magnetic Nano material;
The chromatographic condition of described high-performance liquid chromatogram determination is: fixing the analysis chromatographic column mutually for C18, eluent is volume ratio The mixed liquor of the first alcohol and water of 50 50, type of elution is isocratic elution;Flow velocity is 1.0mL/min;Sample size is 10 μ L, column temperature 25℃;The detection wavelength of ultraviolet-visible photodiode array detector is 665nm;
Described eluant is the one in methanol, acetonitrile, acetone.
The assay method of hydrogen sulfide in blood the most according to claim 1 and urine, it is characterised in that: described ferric iron Salt is FeCl3·6H2O or Fe2(SO4)3·9H2O, divalent iron salt is FeCl2·4H2O or FeSO4·7H2O。
The assay method of hydrogen sulfide in blood the most according to claim 1 and urine, it is characterised in that: treated Blood refers to take 5mL fresh blood, and 2000r/min is centrifuged 10min, will be settled to 5 with distilled water in serum transfers to centrifuge tube ML prepares.
The assay method of hydrogen sulfide in blood the most according to claim 1 and urine, it is characterised in that: described 0.2% pair of ammonia Base dimethylaniline dihydrochloride solution be 0.1g P-aminodimethylaniline hydrochlorate be dissolved in 50mL 3mol/L hydrochloric acid prepare.
CN201510208671.1A 2015-04-29 2015-04-29 The assay method of hydrogen sulfide in a kind of blood and urine Active CN104865323B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510208671.1A CN104865323B (en) 2015-04-29 2015-04-29 The assay method of hydrogen sulfide in a kind of blood and urine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510208671.1A CN104865323B (en) 2015-04-29 2015-04-29 The assay method of hydrogen sulfide in a kind of blood and urine

Publications (2)

Publication Number Publication Date
CN104865323A CN104865323A (en) 2015-08-26
CN104865323B true CN104865323B (en) 2016-11-30

Family

ID=53911301

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510208671.1A Active CN104865323B (en) 2015-04-29 2015-04-29 The assay method of hydrogen sulfide in a kind of blood and urine

Country Status (1)

Country Link
CN (1) CN104865323B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105891135B (en) * 2016-06-30 2018-09-28 山东理工大学 A method of micro methylene blue in aqueous solution is intuitively shown, quantitative determines and removed using brufen
CN106226443B (en) * 2016-09-21 2019-02-05 昆明理工大学 A method for the detection of bisphenol A by supramolecular solvent extraction combined with magnetic solid phase extraction
CN107037141A (en) * 2016-11-18 2017-08-11 司法部司法鉴定科学技术研究所 A kind of method for detecting thiosulfate ion in blood or urine
CN108276584B (en) * 2018-02-11 2021-03-12 中国烟草总公司郑州烟草研究院 Method for detecting aromatic amine compound in human urine
CN115326990B (en) * 2022-09-02 2024-02-06 北京积水潭医院 Method for detecting hydrogen sulfide in biological sample and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2831581B1 (en) * 2012-03-30 2018-10-03 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Measurement of biologically labile hydrogen sulfide pools
CN103776786A (en) * 2014-02-22 2014-05-07 云南健牛生物科技有限公司 Method for detecting hydrogen sulfide in blood and urine

Also Published As

Publication number Publication date
CN104865323A (en) 2015-08-26

Similar Documents

Publication Publication Date Title
CN104865323B (en) The assay method of hydrogen sulfide in a kind of blood and urine
Crescenzi et al. Determination of clenbuterol in bovine liver by combining matrix solid-phase dispersion and molecularly imprinted solid-phase extraction followed by liquid chromatography/electrospray ion trap multiple-stage mass spectrometry
Suleiman et al. Separation/preconcentration of trace amounts of Cr, Cu and Pb in environmental samples by magnetic solid-phase extraction with Bismuthiol-II-immobilized magnetic nanoparticles and their determination by ICP-OES
CN107413313A (en) A kind of Magnetic solid phases extractant based on covalent organic framework material and its preparation method and application
Chen et al. Determination of mercurial species in fish by inductively coupled plasma mass spectrometry with anion exchange chromatographic separation
JP2010519532A (en) Mass spectrometric quantitative detection of methylmalonic acid and succinic acid using HILIC on zwitterionic stationary phase
CN110346487A (en) ZIF-8@ SiO2Core-shell particles and its preparation method and application
He et al. Facile synthesis of boronic acid-functionalized magnetic metal–organic frameworks for selective extraction and quantification of catecholamines in rat plasma
CN110658280A (en) A method for detecting bisphenol compounds based on magnetic metal-organic framework composites
CN104155376B (en) A kind of detection method of hydrogen sulfide in blood and urine
CN103323550A (en) Method for simultaneously detecting five medicaments in water
CN103769056B (en) The absorption of fragrant phenoxy carboxylic ester type weedicide and one-level metabolin thereof and detection method of content in water sample
CN109331795A (en) A kind of magnetic nanocomposite material and its preparation and application
CN105954404B (en) Using the NH of UIO 662The method of sialic acid content in material measure serum
Sun et al. Simultaneous analysis of two urinary biomarkers of oxidative damage to DNA and RNA based on packed-fiber solid phase extraction coupled with high-performance liquid chromatography
CN104101661B (en) A kind of method for quick of Detection of Magdala in Food Through
CN107199012B (en) A kind of magnetism fullerene nanomaterial and its application in Solid Phase Extraction
CN102731392B (en) A kind of platinum characteristic complexing agent and its preparation method and the application of extraction and enrichment determination of platinum
CN107478731A (en) The pre-treating method of parabens preservative in a kind of detection cosmetics
CN112285243A (en) Processing method, confirmatory detection method and application of drug residue detection in animal tissue samples
Qi et al. Fluorescence “light-up” sensor based on ligand/SiO2@ NH2@ cyanuric chloride nanoparticle interactions in alliance with salt dehydration for berberine detection
CN115078612A (en) Analysis method for detecting chemicals based on modified Cr-MOF
Wan et al. Dummy molecularly imprinted solid phase extraction in a nylon membrane filter for analysis of vardenafil in health care products
Acosta et al. On-line solid phase extraction of Cd from protein fractions of serum using oxidized carbon nanotubes coupled to electrothermal atomization atomic absorption spectrometry
CN106645493B (en) A method for detecting quizalofop-p-ethyl and its metabolite residues in complex matrix

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant